Sci African 19:e01453 Palasz E, Wysocka A, Gasiorowska A et al (2020) BDNF as a promising therapeutic agent in Parkinsons disease
hepatica infection has also been observed by Benzer and Ozan [6]
doi: 10.1016/j.tibs.2014.02.002
Unfortunately, and ironically with the latest FDA restriction: Only large well-funded companies can afford FDA trials Naturally occurring peptides are hard to patent No patent = no financial incentive No incentive = no approval No approval = no legal compounding Thats the present reality, I hope this regulatory and political standstill will resolved in the coming years
These injections are sometimes used to treat various conditions, including skin conditions, liver disease, and certain types of cancer
You can be sure that our practitioners are up to date on the most recent methods, knowledge, and developments within the field